Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070030959> ?p ?o ?g. }
- W2070030959 endingPage "n/a" @default.
- W2070030959 startingPage "n/a" @default.
- W2070030959 abstract "The ability of cancer cells to escape from the natural or immunotherapy-induced antitumor immune response is often associated with alterations in the tumor cell surface expression of Major Histocompatibility Complex (MHC) Class I antigens. Considerable knowledge has been gained on the prevalence of various patterns of MHC Class I defects and the underlying molecular mechanisms in different types of cancer. In contrast, few data are available on the changes in MHC Class I expression happening during the course of cancer immunotherapy. We have recently proposed that the progression or regression of a tumor lesion in cancer patients undergoing immunotherapy could be predetermined by the molecular mechanism responsible for the MHC Class I alteration and not by the type of immunotherapy used, i.e., interleukin-2 (IL-2), Bacillus Calmette-Guèrin (BCG), interferon-alpha (IFN-α), peptides alone, dendritic cells loaded with peptides, protein-bound polysaccharide etc. If the molecular alteration responsible for the changes in MHC Class I expression is reversible by cytokines (“soft” lesion), the MHC Class I expression will be upregulated, the specific T cell–mediated response will increase and the lesion will regress. However, if the molecular defect is structural (“hard” lesion), the MHC Class I expression will remain low, the escape mechanism will prevail and the primary tumor or the metastatic lesion will progress. According to this idea, the nature of the preexisting MHC Class I lesion in the cancer cell has a crucial impact determining the final outcome of cancer immunotherapy. In this article, we discuss the importance of these two types of molecular mechanisms of MHC Class I–altered expression." @default.
- W2070030959 created "2016-06-24" @default.
- W2070030959 creator A5027785940 @default.
- W2070030959 creator A5040597554 @default.
- W2070030959 creator A5091885282 @default.
- W2070030959 date "2010-02-22" @default.
- W2070030959 modified "2023-10-17" @default.
- W2070030959 title "“Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy" @default.
- W2070030959 cites W147897928 @default.
- W2070030959 cites W1495399046 @default.
- W2070030959 cites W1544887050 @default.
- W2070030959 cites W1571428739 @default.
- W2070030959 cites W1572267688 @default.
- W2070030959 cites W1952554789 @default.
- W2070030959 cites W1965505544 @default.
- W2070030959 cites W1967469331 @default.
- W2070030959 cites W1977255671 @default.
- W2070030959 cites W1981267671 @default.
- W2070030959 cites W1982951034 @default.
- W2070030959 cites W1982981861 @default.
- W2070030959 cites W1984484036 @default.
- W2070030959 cites W1988461629 @default.
- W2070030959 cites W1991396576 @default.
- W2070030959 cites W1991785385 @default.
- W2070030959 cites W1992699637 @default.
- W2070030959 cites W1992752083 @default.
- W2070030959 cites W1999149486 @default.
- W2070030959 cites W2005765588 @default.
- W2070030959 cites W2016149207 @default.
- W2070030959 cites W2019286713 @default.
- W2070030959 cites W2020054126 @default.
- W2070030959 cites W2029889317 @default.
- W2070030959 cites W2033720551 @default.
- W2070030959 cites W2035047309 @default.
- W2070030959 cites W2035109715 @default.
- W2070030959 cites W2039268504 @default.
- W2070030959 cites W2041360821 @default.
- W2070030959 cites W2042779365 @default.
- W2070030959 cites W2046451544 @default.
- W2070030959 cites W2048304429 @default.
- W2070030959 cites W2048896826 @default.
- W2070030959 cites W2057023729 @default.
- W2070030959 cites W2057616785 @default.
- W2070030959 cites W2058965350 @default.
- W2070030959 cites W2059378562 @default.
- W2070030959 cites W2063192133 @default.
- W2070030959 cites W2068537935 @default.
- W2070030959 cites W2073673847 @default.
- W2070030959 cites W2077431169 @default.
- W2070030959 cites W2077700955 @default.
- W2070030959 cites W2081265652 @default.
- W2070030959 cites W2088342139 @default.
- W2070030959 cites W2088538447 @default.
- W2070030959 cites W2103018035 @default.
- W2070030959 cites W2105533119 @default.
- W2070030959 cites W2115525587 @default.
- W2070030959 cites W2125467688 @default.
- W2070030959 cites W2134093537 @default.
- W2070030959 cites W2134232737 @default.
- W2070030959 cites W2135808990 @default.
- W2070030959 cites W2138949158 @default.
- W2070030959 cites W2140111836 @default.
- W2070030959 cites W2141355322 @default.
- W2070030959 cites W2152596295 @default.
- W2070030959 cites W2154298769 @default.
- W2070030959 cites W2159956468 @default.
- W2070030959 cites W2160566717 @default.
- W2070030959 cites W2161257907 @default.
- W2070030959 cites W2163188531 @default.
- W2070030959 cites W2164772840 @default.
- W2070030959 cites W2169069665 @default.
- W2070030959 cites W2402525709 @default.
- W2070030959 cites W55284089 @default.
- W2070030959 doi "https://doi.org/10.1002/ijc.25270" @default.
- W2070030959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20178101" @default.
- W2070030959 hasPublicationYear "2010" @default.
- W2070030959 type Work @default.
- W2070030959 sameAs 2070030959 @default.
- W2070030959 citedByCount "125" @default.
- W2070030959 countsByYear W20700309592012 @default.
- W2070030959 countsByYear W20700309592013 @default.
- W2070030959 countsByYear W20700309592014 @default.
- W2070030959 countsByYear W20700309592015 @default.
- W2070030959 countsByYear W20700309592016 @default.
- W2070030959 countsByYear W20700309592017 @default.
- W2070030959 countsByYear W20700309592018 @default.
- W2070030959 countsByYear W20700309592019 @default.
- W2070030959 countsByYear W20700309592020 @default.
- W2070030959 countsByYear W20700309592021 @default.
- W2070030959 countsByYear W20700309592022 @default.
- W2070030959 countsByYear W20700309592023 @default.
- W2070030959 crossrefType "journal-article" @default.
- W2070030959 hasAuthorship W2070030959A5027785940 @default.
- W2070030959 hasAuthorship W2070030959A5040597554 @default.
- W2070030959 hasAuthorship W2070030959A5091885282 @default.
- W2070030959 hasBestOaLocation W20700309591 @default.
- W2070030959 hasConcept C121608353 @default.
- W2070030959 hasConcept C142724271 @default.